127 related articles for article (PubMed ID: 19011769)
1. Defects of FA/BRCA pathway in lymphoma cell lines.
Xiao H; Zhang KJ; Xia B
Int J Hematol; 2008 Dec; 88(5):543-550. PubMed ID: 19011769
[TBL] [Abstract][Full Text] [Related]
2. [Search for Fanconi anemia/BRCA pathway defects in lymphoma cell lines].
Xiao H; Zhang K; Xia B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):506-10. PubMed ID: 18841560
[TBL] [Abstract][Full Text] [Related]
3. Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.
Shen X; Do H; Li Y; Chung WH; Tomasz M; de Winter JP; Xia B; Elledge SJ; Wang W; Li L
Mol Cell; 2009 Sep; 35(5):716-23. PubMed ID: 19748364
[TBL] [Abstract][Full Text] [Related]
4. FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.
Raghunandan M; Chaudhury I; Kelich SL; Hanenberg H; Sobeck A
Cell Cycle; 2015; 14(3):342-53. PubMed ID: 25659033
[TBL] [Abstract][Full Text] [Related]
5. FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase-3 dependent degradation.
Clark DW; Tripathi K; Dorsman JC; Palle K
Oncotarget; 2015 Oct; 6(30):28816-32. PubMed ID: 26336824
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.
Guénard F; Labrie Y; Ouellette G; Joly Beauparlant C; Simard J; ; Durocher F
J Hum Genet; 2008; 53(7):579. PubMed ID: 18414782
[TBL] [Abstract][Full Text] [Related]
7. Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines.
Snyder ER; Ricker JL; Chen Z; Waes CV
Cancer Lett; 2007 Jan; 245(1-2):75-80. PubMed ID: 16466850
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
9. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
10. [Antiproliferative effect of curcumin combined with cyclophosmide on the growth of human lymphoma cell line HT/CTX with drug resistance and its relation with FA/BRCA pathway].
Xiao H; Zhang KJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):804-8. PubMed ID: 18718065
[TBL] [Abstract][Full Text] [Related]
11. [Fanconi anemia and genomic instability].
Kitao H; Fujinaka Y; Kubo N; Nakanoko T; Yoshinaga K; Tokunaga E; Saeki H; Endo K; Morita M; Kakeji Y; Maehara Y
Fukuoka Igaku Zasshi; 2008 Jun; 99(6):115-22. PubMed ID: 18833937
[No Abstract] [Full Text] [Related]
12. New roads to FA/BRCA pathway: H2AX.
Lyakhovich A; Surrallés J
Cell Cycle; 2007 May; 6(9):1019-23. PubMed ID: 17471025
[TBL] [Abstract][Full Text] [Related]
13. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
Kupfer GM; D'Andrea AD
Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210
[TBL] [Abstract][Full Text] [Related]
14. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
[TBL] [Abstract][Full Text] [Related]
15. The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.
Peng M; Litman R; Xie J; Sharma S; Brosh RM; Cantor SB
EMBO J; 2007 Jul; 26(13):3238-49. PubMed ID: 17581638
[TBL] [Abstract][Full Text] [Related]
16. Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma.
Szaumkessel M; Richter J; Giefing M; Jarmuz M; Kiwerska K; Tönnies H; Grenman R; Heidemann S; Szyfter K; Siebert R
Int J Oncol; 2011 Aug; 39(2):505-14. PubMed ID: 21567085
[TBL] [Abstract][Full Text] [Related]
17. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
[TBL] [Abstract][Full Text] [Related]
18. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
[TBL] [Abstract][Full Text] [Related]
19. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
[TBL] [Abstract][Full Text] [Related]
20. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
